The corpus striatum serves a critical function in inhibiting involuntary, intrusive movements.
Abstract
The corpus striatum serves a critical function in inhibiting involuntary, intrusive movements. Striatal degeneration in Huntington's disease results in a loss of motor inhibition, manifested by abnormal involuntary choreiform movements. Sensorimotor inhibition, or "gating", can be measured in humans using the startle reflex: the startle reflex is normally inhibited when the startling stimulus is preceded 30-500 ms earlier by a weak prepulse. In the present study, prepulse inhibition (PPI) was The corpus striatum is thought to facilitate the maintenance of posture and ongoing motor behaviours, and to inhibit or gate inappropriate, involuntary movements.' These critical functions are accomplished via striatal y-aminobutyric acid (GABA) containing efferent projections to portions of the globus pallidus and zona reticulata of the substantia nigra, which in turn modulate thalamic motor nuclei directly or indirectly vi'. the subthalamic nucleus.2 Patients wirn Huntington's disease experience a progressive degeneration of intrinsic striatal cells, particularly the medium spiny, or spiny I, GABAergic efferent neurons.3 4 As a result, striatal gating mechanisms fail and adventitious choreiform movements develop in Huntington's disease, progressing to athetosis.
Impaired gating of motor responses can be quantified from the startle reflex. This reflex is normally inhibited when the stimulus-typically a loud noise or air puff-is preceded about 100 ms earlier by a weak prepulse. 5 Prepulse inhibition (PPI) is an operational measure of sensorimotor gating: the degree to which the involuntary startle response is inhibited by a weak prepulse reflects the amount of sensorimotor gating. The PPI seems to largely reflect hardwired inhibitory gating processes: it is involuntary and not learned, occurring on the first stimulus presentation and persisting thereafter without habituation.5 Startle reflex and PPI can be quantified in humans from the eyeblink component of the reflex with surface EMG recordings from orbicularis oculi. Preclinical measures of startle and PPI in laboratory animals can be accomplished with EMG or accelerometer based measures of individual muscle groups or whole body movement.
As described by Davis and colleagues,6 the acoustic startle reflex is controlled by serial connections between the auditory nerve, cochlea, lateral lemniscus, nucleus reticularis pontis caudalis, and the spinal motoneuron. Whereas the primary startle response is controlled within the pontine reticular formation, startle reflex plasticity-including PPI-is modulated by forebrain circuitry. In rats, PPI seems to be modulated by neural circuitry connecting the hippocampus,78 ventral striatum,9-"2 subpallidum,7 and pedunculopontine tegmental nucleus,"3 which may access the primary startle circuit via pontine tegmental efferents to the nucleus reticularis pontis caudalis. 6 The acoustic startle response was measured between 0900 and 1700 with two different EMG systems (San Diego Instruments, San Diego, CA, USA). Hearing was screened with a Saico audiometer (Saico SCR-2, Assens, Denmark). Subjects were excluded if they showed impairment at 40 dB(A) (1000 Hz). The eyeblink component of the startle reflex was assessed from EMG measurements of orbicularis oculi, as described elsewhere.'8 Briefly, each subject was seated comfortably adjacent to the recording equipment and in view of a trained technician. Two miniature silver/silver chloride electrodes (Sensor Medics, Anaheim, CA, USA) were positioned below and to the right of the subject's right eye, over the orbicularis oculi muscle. Placement was selected such that when subjects were asked to move their eye position virtually no activity was recorded with oscilloscope monitoring. 18 Electrode resistances were <5 kohm. Recorded EMG activity was bandpass filtered (1-1000 Hz), and a 60 Hz notch filter was used to eliminate 60 Hz interference. A ground electrode was placed behind the right ear over the mastoid; EMG activity was digitised and 250 readings of 1 ms were recorded starting at startle stimulus onset. Acoustic startle stimuli were delivered by Telephonics (TDH-39-P, Maico, Minneapolis, MN, USA) headphones, and tactile air puff startle stimuli were delivered from a compressed air tank to the subject's neck via a small rubber tube. Subjects sat upright and were directed to look straight ahead and to stay awake.
Subjects were tested in two separate paradigms. One paradigm (session 1; 11 controls and 11 patients with Huntington's disease) assessed startle amplitude and PPI with two pulse modalities (acoustic and tactile) and three different intervals between prepulse and pulse (30, 60 , and 120 ms). In the initial part of this session, a background 70 dB(A) white noise was followed five minutes later by 73 trials in which a startle response was elicited by a 116 dB(A) 40 ms noise burst. An initial pulse (P-ALONE) trial was followed by 72 trials consisting of six blocks of 12 trials each. Each of these 12-trial blocks included three P-ALONE trials, and nine trials in which pulse was preceded 30, 60, or 120 ms earlier by a prepulse (20 ms burst) that was 15 dB(A) above background ("30 ms", "60 ms", or "120 ms" respectively). In the later part of this session, 31 tactile trials were given. An initial PUFF trial consisted of a 30 pounds/square inch air puff delivered through a rubber tube placed about 5 cm from the subject's suprasternal notch. Tube diameter was 4 mm with air pressure delivery regulated at the air supply. The initial PUFF trial was followed by five blocks of six trials that were either PUFF or PUFF preceded 120 ms by an acoustic prepulse as described earlier (prepulse + PUFF). For acoustic and tactile trials, a variable between trial interval averaged 15 seconds. Session 1 used one stationary EMG system located in a research laboratory (DLB) and covered a period of about 1-5 years.
A second paradigm (session 2; 11 controls and 11 patients with Huntington's disease, none of whom were tested in session 1) assessed startle amplitude and PPI using acoustic stimuli only, a single prepulse interval (60 ms), and four different prepulse intensities (2, 4, 8, and 16 dB(A) above background). A background 70 dB(A) white noise was followed five minutes later by 72 startle trials consisting of three conditions: (1) a 118 dB(A) 40 ms noise burst presented alone (P-ALONE); (2) the same 118 dB(A) 40 ms noise burst preceded 60 ms by prepulses (20 ms noise bursts) that were 2, 4, 8, or 16 dB(A) above background (PP2, PP4, PP8, or PP16); or (3) no stimulus. These six trial types were repeated six times in pseudorandom order; this block of 36 trials was repeated twice for a total of 72 trials. A variable between trial interval averaged 30 seconds. Session 2 used a portable EMG system in the UCSD Huntington's disease clinic, over roughly a 1-5 year period. Startle sessions are not painful, and are approved by our Human Subjects Institutional Review Board.
To assess the level of "cognitive" inhibitory deficits in these patients with Huntington's disease, the Stroop test'9 was given to most subjects tested in session 2. Briefly, subjects read for 45 seconds from a standardised list of the words, "blue", "green", or "red", presented in random order, and the number of words correctly read in that 45 second period was recorded (word task score). Next, for 45 seconds subjects named the colour of patterns within a standardised list of blue, green, or red coloured patterns presented in random order, and the number of colours correctly identified in that period was recorded (colour task score). Finally, subjects identified the colour of ink that was mismatched to a word (for example, the word "red" printed in blue ink should be identified as "blue"), and the number of correct responses in a 45 second period was recorded (interference task score). The Stroop test has been used as a measure of cognitive inhibition, because the interference task requires the subject to inhibit or gate the response to the semantic value of the word and to attend to its colour content.'9 Our previous studies have found no significant correlation between PPI and Stroop interference scores in a normal population. 2 Dependent measures for the startle reflex included startle amplitude, peak startle latency, reflex habituation, and PPI. All amplitude measurements were based on the first component (R,) of the startle response.
For tactile trials, latencies were corrected for the 18 ms delay between computer generated stimulus onset and delivery of the air puff stimulus. The PPI was defined as the % reduction in startle amplitude in the presence of the prepulse compared with the amplitude in the absence of the prepulse (100 -(100 x amplitude on prepulse trial/amplitude on P-ALONE trial)). Thus a large "% score" indicates more PPI, whereas a smaller "% score" indicates less PPI. Statistical analyses consisted of mixed design analyses of variance (ANOVAs) with appropriate post hoc tests. Amplitude of P-ALONE and PPI were analysed by two way ANOVAs with repeated measures on trial type (within subject) and diagnosis (between subject). The a value was 0 05.
As in other studies of human startle response, 18 2 321 some subjects in each group were characterised by a relative lack of startle stimulus elicited eyeblink EMG activity and were therefore eliminated from the subsequent analyses of startle data. , and 17 78 respectively).
Control subjects showed the normal modulatory pattern of PPI, in this case with more inhibition elicited by more intense prepulses, whereas patients with Huntington's disease failed to show this modulatory effect of increasing prepulse intensity. The PPI in patients with Huntington's disease in session 2 averaged negative values: startle amplitude on prepulse trials was actually increased compared with amplitude on P-ALONE trials in this Huntington's disease group. Prepulse potentiation has been reported in humans using 2000 ms prepulse intervals,2' and in rats treated with the D2 dopamine agonist quinpirole.22 Whereas several individual patients with Huntington's disease in session 1 exhibited prepulse potentiation, the average positive PPI values in the session 1 Huntington's disease group may reflect differences from session 2 either in the trial parameters, session design, patient characteristics, or EMG recording systems. Figure 4 shows the startle latency in session 2. As in session 1, peak latency was significantly increased in patients with Huntington's disease compared with controls, and again, the modulatory effects of prepulses on reflex Figure 3 Prepulse inhibition of acoustic startle in patients with Huntington's disease (HD; n = 11) and normal controls (n = 11) in session 2. * Significant effect of diagnosis, p < 0-05. We assessed the relation between cognitive impairment-as reflected by dementia rating scale scores-and startle abnormalities in patients with Huntington's disease by simple regression analyses. There was no significant correlation between dementia rating scale scores and PPI for any prepulse condition in session 1 or session 2 (0-38 > r > -058; p > 0-05 all comparisons). As nearly identical P-ALONE stimuli were used in session 1 and session 2, P-ALONE latencies were pooled from these two sessions. A simple regression analysis showed a significant correlation between startle latency and dementia rating scale scores, with longer reflex latencies associated with lower dementia rating scale scores (r = -0 77, p < 0-0005). Similar correlations were noted when latencies from session 1 and session 2 were analysed separately (session 1: r =-0-71; session 2: r= -0-71). As age was significantly correlated with reflex latency in session 1, it is important that there was no significant relation between age and dementia rating scale score (r = -0O24, NS).
Shoulon and Fahn ratings of total functional capacity (13 = normal, 0 = require total care)24 were available on 10 subjects at the time of testing for session 2. Correlations between total functional capacity and PPI were positive, but not statistically significant, for all prepulse conditions (0 50 > r > 0 19; p >0 05 all comparisons). It is interesting that the only two patients with Huntington's disease who exhibited consistent PPI (mean PPI across all conditions = 32 7%) had the highest total functional capacity scores (10 and 12) ; the remaining eight exhibited no overall prepulse inhibition (mean PPI across all conditions = -25 7) and had low total functional capacity scores (mean = 5 38) . Chorea ratings,25 available for 10 patients, did not correlate significantly with mean PPI (r = -0.12). Results from the Stroop test (table) showed expected deficits in all three Stroop conditions in patients with Huntington's disease. 26 Compared with controls, patients with Huntington's disease recorded lower scores in the word task (F=43.54, df 1,16, p< 0.0001), the colour task (F = 180-42, df 1,16, p < 0-000 1), and the interference task (F = 86-55, df 1,16, p < 0.0001). The relative interference score, calculated as the word score divided by the interference score, was significantly greater in patients with Huntington's disease than in controls (F = 4-52, df 1,16, p < 0 05). This suggests that compared with controls, patients with Huntington's disease had more difficulty in the interference condition relative to their own "baseline" word scores.
Correlations of Stroop test scores, dementia rating scale scores, and startle latencies showed that slowing of the startle reflex in patients with Huntington's disease was significantly correlated with performance in the word task (r = -0-76, p < 0-05), and with the relative interference score (r = -0-80, p < 0 02), but not with performance in the colour or interference tasks (R = -0-26 and -005, respectively; p > 0 05, both comparisons The possibility that age alone accounts for the reflex abnormalities in patients with Huntington's disease is refuted by the finding that PPI and startle latency do not significantly correlate with age in normal controls in the present study and in previous studies with larger samples.20 The stronger correlation of age with gating failure and increased reflex latency in patients with Huntington's disease suggests that these abnormalities are linked to the disease progression in Huntington's disease. This interpretation must be made with caution given the small samples in the present study.
Previous studies have reported abnormalities in the blink reflex in patients with Huntington's disease. Increased latency and reduced habituation of electrically evoked blinks were noted in patients with Huntington's disease compared with normal controls and unaffected family members.28 This is consistent with our present findings of increased latency in both acoustic and tactile startle responses in patients with Huntington's disease. Reflex slowing in such patients was correlated significantly with the degree of cognitive impairment measured by the dementia rating scale, and was also correlated significantly with the performance disruptive effects of interference on the Stroop test. The failure to detect habituation deficits in our study might reflect the fact that the paradigm used is not designed to be optimally sensitive to changes in habituation, which are best detected by multiple presentations of a single stimulus type. Others, however, have reported normal or even enhanced habituation of electrically stimulated blinks in patients with Huntington's disease.9
We have no direct evidence that the loss of PPI in our patients reflects degenerative changes within the striatum. Such evidence would include significant correlations between PPI and neuroimaging detected volume changes or metabolic changes in the striatum in these patients. This experimental approach has been initiated in studies of PPI in patients with schizophrenia, in whom there is a significant negative correlation (R = -077) between PPI and lenticular nucleus volume assessed by MRI. 3 In summary, sensorimotor gating is impaired in patients with Huntington's disease compared with controls. The loss of sensorimotor gating is evident in both acoustic and tactile modalities, but is accompanied by normal startle amplitude, normal habituation, and normal prepulse latency facilitation. The pattern of impaired gating in Huntington's disease is distinct from the pattern of deficits previously reported in patients with schizophrenia or obsessive compulsive disorder, and suggests a complete or near complete disconnection of forebrain modulatory influences on "primary" startle circuitry in the reticular formation in Huntington's disease.
